Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study

B Šumová, LA Cerezo, L Szczuková… - Rheumatology …, 2019 - Springer
S100 proteins are currently being investigated as potential diagnostic and prognostic biomarkers
of several cancers and inflammatory diseases. The aims of this study were to analyse …

[HTML][HTML] The relationship between synovitis quantified by an ultrasound 7-joint inflammation score and physical disability in rheumatoid arthritis–a cohort study

J Závada, P Hánová, J Hurňáková, L Szczuková… - Arthritis research & …, 2017 - Springer
Background Restoring normal physical functioning is a major therapeutic aim in the management
of rheumatoid arthritis (RA). It is unknown, whether the extent of synovial inflammation …

Cross-sectional study of patients with axial spondyloarthritis fulfilling imaging arm of ASAS classification criteria: baseline clinical characteristics and subset …

K Bubová, Š Forejtová, K Zegzulková, M Gregová… - BMJ open, 2019 - bmjopen.bmj.com
Objective This study compared demographic, clinical and laboratory characteristics between
patients with radiographic and non-radiographic axial spondyloarthritis (axSpA). Methods …

Tumor necrosis factor inhibitor monotherapy versus combination therapy for the treatment of psoriatic arthritis: combined analysis of European biologics databases

ML Thomas, G Shaddick, R Charlton, C Cavill… - The journal of …, 2021 - jrheum.org
Objective. To investigate whether tumor necrosis factor inhibitor (TNFi) combination therapy
with conventional synthetic disease-modifying antirheumatic drugs (csDMARD) is more …

THU0650 The effect of anti-tnf therapy on work productivity and activity impairment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis …

J Zavada, L Szczukova, K Pavelka, P Horák… - 2017 - ard.bmj.com
Objectives To assess the effect of anti-TNF therapy on work productivity using the Work
Productivity and Activity Impairment-Specific Health Problem (WPAI-SHP) questionnaire in …

[CITATION][C] A non-medical switch from originator infliximab to biosimilar CT-p13 in 36 patients with ankylosing spondylitis: 6-months clinical outcomes from the Czech …

…, J Zavada, L Szczukova… - ARTHRITIS & …, 2017 - … ST, HOBOKEN 07030-5774, NJ USA

[CITATION][C] Treatment of Adult Juvenile Idiopathic Arthritis Patients with Biologic Agents. Data from the National Registry

K Jarosova, L Szczukova… - ARTHRITIS & …, 2017 - … ST, HOBOKEN 07030-5774, NJ USA

[CITATION][C] Léčba revmatoidní artritidy preparáty biologické léčby v České republice: Základní přehled a hodnocení účinnosti a bezpečnosti léčby z dat registru …

M Uher, L Szczuková, K Hejduk - 2015 - med.muni.cz
Léčba revmatoidní artritidy preparáty biologické léčby v České republice: Základní přehled
a hodnocení účinnosti a bezpečnosti léčby z dat registru ATTRA | Faculty of Medicine …

[CITATION][C] Synovitis Assessed By the German 7-Joint Ultrasound Score (US7S) Is Associated with the Reversible Activity-Related Component of Physical Disability in …

…, J Hurnakova, L Szczukova… - ARTHRITIS & …, 2016 - … ST, HOBOKEN 07030-5774, NJ USA